CIK 0001468929 · <br>Emerging growth company
NEXGEL, INC.
Sign in to watch- Ticker
- NXGL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264042544
- Phone
- 215 702-8550
- Business address
- 2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
- Former names
- NEXGEL, INC., AquaMed Technologies, Inc.
Securities
- NXGL Common Stock Nasdaq
- NXGLW Warrant Nasdaq
- Open-market buys, last 90 days
- $757,691
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$757,691. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | glassman steven mark Director | Returned to the company · Convertible Promissory Note (before amendment) | +2,084 | 0 | ||
| 2026-11-10 | glassman steven mark Director | Grant or award · Convertible Promissory Note (as amended) | +4,546 | 4,546 | ||
| 2026-11-10 | glassman steven mark Director | Returned to the company · Warrant to Purchase Common Stock | +1,042 | 0 | ||
| 2026-11-10 | glassman steven mark Director | Grant or award · Existing Warrant (as amended) | +1,042 | 1,042 | ||
| 2026-07-23 | Levy Adam R. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2026-06-23 | Levy Adam R. Chief Executive Officer | Sale | −5,000 | $0.59 | $3K | 322,692 |
| 2026-06-18 | Levy Adam R. Chief Executive Officer | Sale | −6,000 | $0.59 | $4K | 327,692 |
| 2026-06-11 | Levy Adam R. Chief Executive Officer | Sale | −3,000 | $0.61 | $2K | 333,692 |
| 2026-06-08 | Levy Adam R. Chief Executive Officer | Sale | −3,000 | $0.55 | $2K | 336,692 |
| 2026-06-04 | Levy Adam R. Chief Executive Officer | Sale | −3,000 | $0.59 | $2K | 339,692 |
| 2026-06-01 | Levy Adam R. Chief Executive Officer | Sale | −2,000 | $0.59 | $1K | 342,692 |
| 2026-05-29 | Levy Adam R. Chief Executive Officer | Sale | −3,000 | $0.60 | $2K | 344,692 |
| 2026-05-28 | Levy Adam R. Chief Executive Officer | Sale | −7,000 | $0.61 | $4K | 347,692 |
| 2026-05-27 | Levy Adam R. Chief Executive Officer | Sale | −3,000 | $0.60 | $2K | 354,692 |
| 2026-05-14 | Henry Scott Robert Director | Purchase · Convertible Promissory Note (the "Note") | +41,667 | $0.60 | $25K | 41,667 |
| 2026-05-14 | Henry Scott Robert Director | Purchase · Warrant to Purchase Common Stock (the "Warrant") | +20,834 | 20,834 | ||
| 2026-05-14 | Levy Adam R. Chief Executive Officer | Purchase · Convertible Promissory Note (the "Note") | +100,000 | $0.60 | $60K | 100,000 |
| 2026-05-14 | Levy Adam R. Chief Executive Officer | Purchase · Warrant to Purchase Common Stock (the "Warrant") | +50,000 | 50,000 | ||
| 2026-05-11 | Kieser Brian Joseph Director | Purchase · Convertible Promissory Note (the "Note") | +1,666,667 | $0.60 | $1.0M | 1,666,667 |
| 2026-05-11 | Kieser Brian Joseph Director | Purchase · Warrant to Purchase Common Stock (the "Warrant") | +833,334 | 833,334 |
Page 2 of 9 · 176 trades